F-star, an invoX company
F-star, an invoX company, is a privately held biotechnology firm headquartered in Cambridge, UK, founded in 2007, with 51-100 employees. It operates as a portfolio company of invoX and develops within the biologics/biotech sector. Specific products and customers are not disclosed in available input.
- Company typePrivate
- Founded2006
- HeadquartersCambridge, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
F-star, an invoX company firmographics
Firmographics- Name
- F-star, an invoX company
- Legal name
- F-star
- Website
- https://f-star.com
- Company type
- Private
- Founded year
- 2006
- Headcount range
- 51–100 employees
- Short description
- F-star, an invoX company, is a privately held biotechnology firm headquartered in Cambridge, UK, founded in 2007, with 51-100 employees. It operates as a portfolio company of invoX and develops within the biologics/biotech sector. Specific products and customers are not disclosed in available input.
- Ownership category
- akta.pro rank
Where F-star, an invoX company is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
F-star, an invoX company business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations
F-star, an invoX company product offering
Product offeringCore offering
F-star is a biotechnology company developing biological therapeutic products within the broader life-sciences sector. The source data does not enumerate specific products, therapeutic targets, or scientific platforms. As a Cambridge, UK-based biotech founded in 2007 operating under invoX, the firm is most consistent with a clinical-stage therapeutic developer whose commercial offerings are biological candidates and associated intellectual property.
Differentiator
Problem solved
Functional benefit
Companies that use F-star, an invoX company
Customer profileIdeal customer profiles1 record
F-star, an invoX company technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
F-star, an invoX company competitors and assessment
Company assessmentDirect peers
- MacroGenics: MacroGenics develops bispecific antibodies and antibody-based therapeutics for cancer, using platforms like DART. Direct competitor to F-star's bispecific antibody pipeline.
- Xencor: Xencor engineers bispecific antibodies and cytokines with its XmAb platform, targeting oncology and autoimmune diseases. Comparable in therapeutic focus and engineered antibody technology approach.
- Zymeworks: Zymeworks develops bispecific and multifunctional antibody therapeutics using its Azymetric and EffiFunction platforms. Direct comparable as a mid-sized bispecific antibody developer.
- Genmab: Genmab is a Denmark-based biotech specializing in antibody therapeutics, including bispecific platforms (DuoBody). Directly comparable to F-star as a privately developed bispecific antibody platform targeting oncology and immunology indications.
Emerging players
- Compugen: Compugen uses computational biology to discover and develop therapeutic antibodies and immuno-oncology candidates. Comparable as a discovery-focused therapeutic biotech with platform methodology.
- AbCellera: AbCellera is an antibody discovery platform company using single-cell screening to develop therapeutic antibodies. Adjacent comparator as another antibody-focused biotech with platform-driven discovery operations.
- CytomX Therapeutics: CytomX develops conditionally activated antibody therapeutics (Probody platform) for oncology. Overlap as a biotech engineering next-generation antibody modalities with oncology focus.
- Adimab: Adimab operates a proprietary antibody discovery and engineering platform serving biotech and pharma partners. Comparable as a platform-based antibody company pursuing partnerships and internal pipeline development.
- Mersana Therapeutics: Mersana develops antibody-drug conjugates and next-generation biologics for cancer. Comparable as a mid-stage clinical biotech working on engineered therapeutic biologics.
Broad incumbents
- invoX Pharma: invoX Pharma is the parent group that owns F-star and a portfolio of other pharma and biotech businesses. Comparable as the broader holding entity encompassing F-star's operations and as a buyer of similar therapeutic biotech assets.
Market position
Customer concentration
F-star, an invoX company social profiles
Digital presenceF-star, an invoX company financial estimates
Financial estimateRevenue estimate
Valuation estimate
F-star, an invoX company leadership team
Management profileNumber of profiles
F-star, an invoX company funding detail
Funding detailFunding overview
Funding rounds8 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
F-star, an invoX company M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about F-star, an invoX company
What does F-star, an invoX company do?
F-star is a biotechnology company developing biological therapeutic products within the broader life-sciences sector. The source data does not enumerate specific products, therapeutic targets, or scientific platforms. As a Cambridge, UK-based biotech founded in 2007 operating under invoX, the firm is most consistent with a clinical-stage therapeutic developer whose commercial offerings are biological candidates and associated intellectual property.
When was F-star, an invoX company founded?
F-star, an invoX company was founded in 2006. It employs 51 to 100 people.
Where is F-star, an invoX company based?
F-star, an invoX company is headquartered in Cambridge, United Kingdom, in the Europe region.
Who are F-star, an invoX company's main competitors?
Direct peers on record are MacroGenics, Xencor, Zymeworks and Genmab. Emerging players are Compugen, AbCellera, CytomX Therapeutics, Adimab and Mersana Therapeutics. invoX Pharma is listed as a broad incumbent.
Does F-star, an invoX company have an API?
No public API is recorded for F-star, an invoX company.